E
Enlivex Ltd. (ENLV)
NCM – Real Time Price. Currency in USD
0.75
+0.01 (0.82%)
At close: May 12, 2026, 4:00 PM EDT
0.75
0.00 (0.00%)
After-hours: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.75
+0.01 (0.82%)
At close: May 12, 2026, 4:00 PM EDT
0.75
0.00 (0.00%)
After-hours: May 12, 2026, 4:00 PM EDT
Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.
| Name | Position |
|---|---|
| Dr. Einat Galamidi M.D. | Chief Medical Officer |
| Dr. Oren Hershkovitz Ph.D. | Chief Executive Officer |
| Dr. Veronique Amor-Baroukh | Senior Director of Operations |
| Mr. Shai Novik M.B.A. | Executive Chairman |
| Ms. Shachar Shlosberger CPA | Chief Financial Officer |
| Ms. Sigal Arad | Director of Human Resources |
| Prof. Dror Mevorach M.D. | Founder & Scientific Advisor |
| Date | Type | Document |
|---|---|---|
| 2026-04-21 | F-3 | ea0286920-f3_enlivex.htm |
| 2026-04-08 | 6-K | ea0285376-6k_enlivex.htm |
| 2026-03-26 | 6-K | ea028345301-6k_enlivex.htm |
| 2026-03-25 | 6-K | ea0283248-6k_enlivex.htm |
| 2026-03-25 | 20-F | ea0282960-20f_enlivex.htm |
| 2026-03-24 | 6-K | ea0283045-6k_enlivex.htm |
| 2026-03-23 | 6-K | ea0282900-6k_enlivex.htm |
| 2026-03-13 | S-8 | ea0281372-s8_enlivex.htm |
| 2026-02-23 | 6-K | ea0277907-6k_enlivex.htm |
| 2026-02-10 | 6-K | ea0276174-6k_enlivex.htm |